… Leadership ProQR's leadership is a strong team with proven track record. … develop RNA therapies for rare diseases. Before founding ProQR, Daniel was founder and Chief Executive Officer of … and development and is currently in charge of our R&D. Gerard has more than 25 years of senior managerial …
… Investors & Media ProQR Investor and Media page. Located in Leiden, Netherlands and Cambridge, Mass., ProQR Therapeutics (Nasdaq:PRQR) is a biotechnology company … through the creation of transformative RNA therapies. ProQR is pioneering a next-generation RNA technology called …
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
If you would like to join the team at ProQR but you can't find the right job opening at this moment, you are welcome to send us an open application via our connect portal!
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
… Here is a list of the research analysts that cover ProQR Therapeutics (Nasdaq: $PRQR). ProQR Therapeutics is followed by the analysts listed below. … note that any opinions, estimates or forecasts regarding ProQR's performance made by these analysts are theirs alone …
Check out our vacancies! We are looking for people who are inspired by our mission to edit RNA, treat disease and change lives. Are you up for the challenge?
… Science At ProQR science is literally at the heart of what we do. Our … and translating them to life-changing treatments. At ProQR science is literally at the heart of what we do. The … with rare genetic diseases. Axiomer RNA base editing At ProQR we invented the Axiomer™ technology that enables single …
At ProQR, we are dedicated to improving the lives of patients and families affected by rare and common disorders using Axiomer, our innovative RNA editing platform technology.
